Insider Transactions in Q2 2023 at Ultragenyx Pharmaceutical Inc. (RARE)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Corazon (Corsee) D. Sanders |
SELL
Open market or private sale
|
Direct |
585
-6.11%
|
$26,910
$46.76 P/Share
|
|
Jun 19
2023
|
Erik Harris EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
305
-0.53%
|
$14,640
$48.2 P/Share
|
|
Jun 08
2023
|
Corazon (Corsee) D. Sanders |
SELL
Open market or private sale
|
Direct |
1,485
-13.43%
|
$75,735
$51.65 P/Share
|
|
Jun 07
2023
|
Deborah Dunsire |
BUY
Grant, award, or other acquisition
|
Direct |
3,860
+16.36%
|
-
|
|
Jun 07
2023
|
Michael Narachi |
BUY
Grant, award, or other acquisition
|
Direct |
3,860
+15.16%
|
-
|
|
Jun 07
2023
|
Shehnaaz Suliman |
BUY
Grant, award, or other acquisition
|
Direct |
3,860
+20.63%
|
-
|
|
Jun 07
2023
|
Corazon (Corsee) D. Sanders |
BUY
Grant, award, or other acquisition
|
Direct |
3,860
+25.88%
|
-
|
|
Jun 07
2023
|
Matthew K Fust |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,300
-10.87%
|
$168,300
$51.82 P/Share
|
|
Jun 07
2023
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
3,860
+11.28%
|
-
|
|
Jun 07
2023
|
Amrit Ray |
BUY
Grant, award, or other acquisition
|
Direct |
3,860
+23.92%
|
-
|
|
Jun 07
2023
|
Daniel G Welch |
BUY
Grant, award, or other acquisition
|
Direct |
3,860
+15.16%
|
-
|
|
May 18
2023
|
John Richard Pinion |
SELL
Open market or private sale
|
Direct |
2,012
-2.62%
|
$100,600
$50.0 P/Share
|
|
May 09
2023
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+8.89%
|
$63,000
$21.0 P/Share
|
|
May 04
2023
|
Karah Herdman Parschauer EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,378
-7.77%
|
$197,010
$45.0 P/Share
|
|
May 01
2023
|
Eric Crombez EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,658
+13.24%
|
-
|
|
Apr 16
2023
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
181
-0.65%
|
$6,878
$38.2 P/Share
|
|
Apr 16
2023
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14
-0.05%
|
$532
$38.2 P/Share
|